Ahead of today’s opening bell, Dow futures pre market rose by 0.3%, supported by a stronger euro-dollar exchange rate that could benefit multinational revenues. Traders are recalibrating based on export dynamics. Shares of British pharmaceutical maker GSK ( GSK ) are higher in premarket trading after the company announced it is replacing its chief executive officer. Current CEO Emma Walmsley, who has led the company for nine years, will step down for the position on Jan. 1 and be replaced by the company's chief commercial officer, Luke Miels. The company last year agreed to pay up to $2.2 billion to resolve thousands of lawsuits over allegations that its Zantac heartburn medication caused cancer. U.S.-traded shares of GSK were up about 3% ahead of the bell. Coming into today's session, the stock had gained 18% so far in 2025. U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. Dow futures pre market shows a lift of 70 points on renewed buying interest in financials, following stronger profit margins reported by major banks. Analysts see potential for a short-term rally if macro data doesn’t disappoint.
